QNTA - Quanta, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1890
-0.0110 (-5.50%)
At close: 2:37PM EDT
Stock chart is not supported by your current browser
Previous Close0.2000
Open0.2000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1310 - 0.2000
52 Week Range0.1002 - 19.0000
Volume52,814
Avg. Volume28,583
Market Cap8.438M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0090
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • A Quantum Union: Quanta, Inc & RST-Sanexas Announce Partnership
    PR Newswire

    A Quantum Union: Quanta, Inc & RST-Sanexas Announce Partnership

    Quanta, Inc. (QNTA: OTC) and Resonant Specific Technologies, Inc. announced a medical industry partnership today wherein Quanta will co-brand and supply its Muscle Rub to assist in reducing patient discomfort as an adjunct to treatment protocols that use RST-Sanexas neoGEN Electric Cell Signaling Treatment (EcST) devices in physician offices, clinics and hospitals to facilitate patient's pain management and discomfort.

  • Quanta, Inc. Announces $6.1M Raise -- Connecticut-Based Southridge Leads Group Investment in Applied Science Products Producer
    PR Newswire

    Quanta, Inc. Announces $6.1M Raise -- Connecticut-Based Southridge Leads Group Investment in Applied Science Products Producer

    Quanta, Inc. (OTC: QNTA), an applied science company, focused on enhancing energy levels in plant matter, to increase performance within the human body, announced this week a $6.1 million capital raise with $1.6M in a direct investment. With an additional $4.5M direct investment still to come, as requested by the company. Led by Conn.-based Southridge and including three other individual investors, this raise comes on the back of a successful Q3 for Quanta, Inc. The Company recently filed their 10-Q, showing an increase in revenue by 23.8% over Q2.

  • PR Newswire

    Quanta Announces Successful Q2 Sales Growth of Flagship Polarized Products

    LOS ANGELES , Aug. 23, 2019 /PRNewswire/ -- Quanta, Inc. (OTC: QNTA), an applied science company, focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance ...

  • PR Newswire

    Quanta Partners with Influential Pharmacy Distribution and Marketing Company PharmaLynk

    LOS ANGELES, July 31, 2019 /PRNewswire/ -- Quanta Inc. (QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, announced today that it has partnered with PharmaLynk. PharmaLynk is known for their distribution of unique and effective health products through their existing network to over 1000+ independent pharmacies nationwide.

  • PR Newswire

    Quanta announces Annabelle Manalo, PhD will join its board of advisors

    LOS ANGELES, July 9, 2019 /PRNewswire/ -- Quanta, Inc. (QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, announced today that Annabelle Manalo, PhD will join their board of advisors to help lead innovation from within its team of expert scientists. Annabelle Dr. Manalo is a mother of four, a scientist, an educator and a respected thought leader. She is a cell and developmental biologist from Vanderbilt University in Nashville, Tennessee with a background in neuroscience from Georgetown University.

  • PR Newswire

    Polarization Technology Increases CBD's Ability to Reduce Inflammation by More Than 500%

    LOS ANGELES, July 2, 2019 /PRNewswire/ -- Quanta, Inc. (QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, announced today that they released a new white paper "CBD in the Quantum Era - Polarization and its effects on anti-inflammatory abilities of cannabidiol (CBD)" which shows that Quanta's patented polarization technology increases the effectiveness of CBD to inhibit the COX 2 enzyme by 572%. In other words, the polarization process greatly increases the ability of CBD to reduce inflammation. Quanta's proprietary technology uses quantum mechanics to increase the bio-activity of targeted molecules which enhances the desired effect.

  • PR Newswire

    Dr. Arthur Mikaelian, becomes Quanta's Chief Science Officer and is named to the Board of Directors

    Dr. Arthur Mikaelian will be focused on leading Quanta's science team in further enhancing the quality of all Quanta products by increasing the bioactivity of all ingredients used in Quanta formulations.

  • PR Newswire

    Quanta Partners with Online Powerhouse Kapno

    LOS ANGELES , June 11, 2019 /PRNewswire/ -- Quanta, Inc. (OTC: QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance ...

  • PR Newswire

    Quanta Partners with Skogen's Festival Foods Grocery Stores

    LOS ANGELES , June 7, 2019 /PRNewswire/ -- Quanta Inc. (OTC: QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within ...

  • PR Newswire

    Quanta Inc. Announces LOI with Global Cannabinoids for Exclusive Nationwide Wholesale and Licensing Agreement

    LOS ANGELES , June 4, 2019 /PRNewswire/ -- Quanta Inc. (OTC: QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within ...

  • ACCESSWIRE

    Quanta Launches Proprietary Polarized CBD Product Lines

    LOS ANGELES, CA / ACCESSWIRE / January 10, 2019 / Quanta, Inc. (OTC PINK: QNTA) an applied science company, focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, today announced that it will begin manufacturing its own line of polarized cannabidiol (CBD) products due to recent passage of the 2018 Farm Bill. Quanta will continue its previously agreed upon licensing arrangement with THC manufacturers.